APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiasthmatic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antiasthmatic Drug Industry Growth and Trends Forecast to 2032

2 January 2026123 pages

Choose your research edition.

Industry ResearchAntiasthmatic Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiasthmatic Drug Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Antiasthmatic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiasthmatic Drug Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiasthmatic Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Antiasthmatic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Antiasthmatic Drug market include Ruiyang Pharmaceutical Co., Ltd, Novartis AG, Roche, Lunan Pharmaceutical Group Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, GlaxoSmithKline, Fuhe Group, Chengdu Huayu Pharmaceutical Co., Ltd and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiasthmatic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiasthmatic Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiasthmatic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiasthmatic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Antiasthmatic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiasthmatic Drug Market by Company

Ruiyang Pharmaceutical Co., Ltd

Novartis AG

Roche

Lunan Pharmaceutical Group Co., Ltd

Kaifeng Kangnuo Pharmaceutical Co., Ltd

GlaxoSmithKline

Fuhe Group

Chengdu Huayu Pharmaceutical Co., Ltd

AstraZeneca

Teva Pharmaceutical Industries Ltd

Mundipharma Pharmaceuticals Ltd.

MSD

Kyorin Pharmaceutical Co.,Ltd.

Kissei Pharmaceutical Co.Ltd.

Daiichi Sankyo Company Limited

Covis Pharmaceutical Inc

Chiesi GmbH

Boehringer Ingelheim Pharma GmbH&Co.KG

Akorn Pharmaceutical Co.Ltd.

ABC Farmaceutici Spa

Antiasthmatic Drug Segment by Type

Anti-allergic Antiasthmatic

Anti-inflammatory Antiasthmatic

Bronchodilators

Antiasthmatic Drug Segment by Application

Hospital

Clinic

Other

Antiasthmatic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiasthmatic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiasthmatic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiasthmatic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Antiasthmatic Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Antiasthmatic Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Antiasthmatic Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Antiasthmatic Drug Market Share by Region (2021-2026) Table 4. Global Antiasthmatic Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Antiasthmatic Drug Market Share by Region (2027-2032) Table 6. Global Antiasthmatic Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Antiasthmatic Drug Market Size Share by Type (2021-2026) Table 9. Global Antiasthmatic Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Antiasthmatic Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Antiasthmatic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Antiasthmatic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Antiasthmatic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Antiasthmatic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Antiasthmatic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Antiasthmatic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Antiasthmatic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Antiasthmatic Drug Market Size Share by Application (2021-2026) Table 24. Global Antiasthmatic Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Antiasthmatic Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Antiasthmatic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Antiasthmatic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Antiasthmatic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Antiasthmatic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Antiasthmatic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Antiasthmatic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Antiasthmatic Drug Industry Trends Table 37. Antiasthmatic Drug Industry Drivers Table 38. Antiasthmatic Drug Industry Opportunities and Challenges Table 39. Antiasthmatic Drug Industry Restraints Table 40. Global Antiasthmatic Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Antiasthmatic Drug Revenue Market Share by Company (2021-2026) Table 42. Global Antiasthmatic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Antiasthmatic Drug Key Company Headquarters & Area Served Table 44. Global Antiasthmatic Drug Company, Product Type & Application Table 45. Global Antiasthmatic Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Antiasthmatic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Ruiyang Pharmaceutical Co., Ltd Company Information Table 49. Ruiyang Pharmaceutical Co., Ltd Business Overview Table 50. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 52. Ruiyang Pharmaceutical Co., Ltd Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Antiasthmatic Drug Product Portfolio Table 57. Novartis AG Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Antiasthmatic Drug Product Portfolio Table 62. Roche Recent Development Table 63. Lunan Pharmaceutical Group Co., Ltd Company Information Table 64. Lunan Pharmaceutical Group Co., Ltd Business Overview Table 65. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio Table 67. Lunan Pharmaceutical Group Co., Ltd Recent Development Table 68. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information Table 69. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview Table 70. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 72. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Antiasthmatic Drug Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Fuhe Group Company Information Table 79. Fuhe Group Business Overview Table 80. Fuhe Group Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Fuhe Group Antiasthmatic Drug Product Portfolio Table 82. Fuhe Group Recent Development Table 83. Chengdu Huayu Pharmaceutical Co., Ltd Company Information Table 84. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview Table 85. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 87. Chengdu Huayu Pharmaceutical Co., Ltd Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca Antiasthmatic Drug Product Portfolio Table 92. AstraZeneca Recent Development Table 93. Teva Pharmaceutical Industries Ltd Company Information Table 94. Teva Pharmaceutical Industries Ltd Business Overview Table 95. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio Table 97. Teva Pharmaceutical Industries Ltd Recent Development Table 98. Mundipharma Pharmaceuticals Ltd. Company Information Table 99. Mundipharma Pharmaceuticals Ltd. Business Overview Table 100. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio Table 102. Mundipharma Pharmaceuticals Ltd. Recent Development Table 103. MSD Company Information Table 104. MSD Business Overview Table 105. MSD Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. MSD Antiasthmatic Drug Product Portfolio Table 107. MSD Recent Development Table 108. Kyorin Pharmaceutical Co.,Ltd. Company Information Table 109. Kyorin Pharmaceutical Co.,Ltd. Business Overview Table 110. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio Table 112. Kyorin Pharmaceutical Co.,Ltd. Recent Development Table 113. Kissei Pharmaceutical Co.Ltd. Company Information Table 114. Kissei Pharmaceutical Co.Ltd. Business Overview Table 115. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio Table 117. Kissei Pharmaceutical Co.Ltd. Recent Development Table 118. Daiichi Sankyo Company Limited Company Information Table 119. Daiichi Sankyo Company Limited Business Overview Table 120. Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio Table 122. Daiichi Sankyo Company Limited Recent Development Table 123. Covis Pharmaceutical Inc Company Information Table 124. Covis Pharmaceutical Inc Business Overview Table 125. Covis Pharmaceutical Inc Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio Table 127. Covis Pharmaceutical Inc Recent Development Table 128. Chiesi GmbH Company Information Table 129. Chiesi GmbH Business Overview Table 130. Chiesi GmbH Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Chiesi GmbH Antiasthmatic Drug Product Portfolio Table 132. Chiesi GmbH Recent Development Table 133. Boehringer Ingelheim Pharma GmbH&Co.KG Company Information Table 134. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview Table 135. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio Table 137. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development Table 138. Akorn Pharmaceutical Co.Ltd. Company Information Table 139. Akorn Pharmaceutical Co.Ltd. Business Overview Table 140. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio Table 142. Akorn Pharmaceutical Co.Ltd. Recent Development Table 143. ABC Farmaceutici Spa Company Information Table 144. ABC Farmaceutici Spa Business Overview Table 145. ABC Farmaceutici Spa Antiasthmatic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio Table 147. ABC Farmaceutici Spa Recent Development Table 148. North America Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Antiasthmatic Drug Market Share by Country (2021-2026) Table 151. North America Antiasthmatic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Antiasthmatic Drug Market Share Forecast by Country (2027-2032) Table 153. Europe Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Antiasthmatic Drug Market Share by Country (2021-2026) Table 156. Europe Antiasthmatic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Antiasthmatic Drug Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Antiasthmatic Drug Market Share by Country (2021-2026) Table 161. Asia-Pacific Antiasthmatic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Antiasthmatic Drug Market Share Forecast by Country (2027-2032) Table 163. Latin America Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Antiasthmatic Drug Market Share by Country (2021-2026) Table 166. Latin America Antiasthmatic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Antiasthmatic Drug Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Antiasthmatic Drug Market Share by Country (2021-2026) Table 171. Middle East & Africa Antiasthmatic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Antiasthmatic Drug Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Antiasthmatic Drug Product Image Figure 3. Global Antiasthmatic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Antiasthmatic Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Antiasthmatic Drug Market Share by Region (2021-2032) Figure 7. North America Antiasthmatic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Antiasthmatic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Antiasthmatic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Anti-allergic Antiasthmatic Image Figure 13. Global Anti-allergic Antiasthmatic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Anti-inflammatory Antiasthmatic Image Figure 15. Global Anti-inflammatory Antiasthmatic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Bronchodilators Image Figure 17. Global Bronchodilators Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Antiasthmatic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Antiasthmatic Drug Market Share by Type 2025 VS 2032 Figure 20. North America Antiasthmatic Drug Market Size Share by Type (2021-2032) Figure 21. Europe Antiasthmatic Drug Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Antiasthmatic Drug Market Size Share by Type (2021-2032) Figure 23. Latin America Antiasthmatic Drug Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Antiasthmatic Drug Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinic Image Figure 28. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Antiasthmatic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antiasthmatic Drug Market Share by Application 2025 VS 2032 Figure 33. North America Antiasthmatic Drug Market Size Share by Application (2021-2032) Figure 34. Europe Antiasthmatic Drug Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Antiasthmatic Drug Market Size Share by Application (2021-2032) Figure 36. Latin America Antiasthmatic Drug Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Antiasthmatic Drug Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Antiasthmatic Drug Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Antiasthmatic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Antiasthmatic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Antiasthmatic Drug Market Share by Country (2021-2032) Figure 43. Europe Antiasthmatic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Antiasthmatic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antiasthmatic Drug Market Share by Country (2021-2032) Figure 46. Asia-Pacific Antiasthmatic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Antiasthmatic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Antiasthmatic Drug Market Share by Country (2021-2032) Figure 49. Latin America Antiasthmatic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Antiasthmatic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Antiasthmatic Drug Market Share by Country (2021-2032) Figure 52. Middle East & Africa Antiasthmatic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Antiasthmatic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Antiasthmatic Drug Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-allergic Antiasthmatic
  • Anti-inflammatory Antiasthmatic
  • Bronchodilators
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Ruiyang Pharmaceutical Co., Ltd
  • Novartis AG
  • Roche
  • Lunan Pharmaceutical Group Co., Ltd
  • Kaifeng Kangnuo Pharmaceutical Co., Ltd
  • GlaxoSmithKline
  • Fuhe Group
  • Chengdu Huayu Pharmaceutical Co., Ltd
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd
  • Mundipharma Pharmaceuticals Ltd.
  • MSD
  • Kyorin Pharmaceutical Co.,Ltd.
  • Kissei Pharmaceutical Co.Ltd.
  • Daiichi Sankyo Company Limited
  • Covis Pharmaceutical Inc
  • Chiesi GmbH
  • Boehringer Ingelheim Pharma GmbH&Co.KG
  • Akorn Pharmaceutical Co.Ltd.
  • ABC Farmaceutici Spa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Antiasthmatic Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Antiasthmatic Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Antiasthmatic Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Antiasthmatic Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Antiasthmatic Drug Market Size (2021-2032)
  8. 1.5.1 North America Antiasthmatic Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Antiasthmatic Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Antiasthmatic Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (2021-2032)
2 Antiasthmatic Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Anti-allergic Antiasthmatic
  3. 2.1.2 Anti-inflammatory Antiasthmatic
  4. 2.1.3 Bronchodilators
  5. 2.2 Global Antiasthmatic Drug Market Size by Type
  6. 2.2.1 Global Antiasthmatic Drug Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Antiasthmatic Drug Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Antiasthmatic Drug Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Antiasthmatic Drug Market Size by Regions
  10. 2.3.1 North America Antiasthmatic Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Antiasthmatic Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Antiasthmatic Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Type (2021-2026)
3 Antiasthmatic Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Antiasthmatic Drug Market Size by Application
  6. 3.2.1 Global Antiasthmatic Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Antiasthmatic Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Antiasthmatic Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Antiasthmatic Drug Market Size by Regions
  10. 3.3.1 North America Antiasthmatic Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Antiasthmatic Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Antiasthmatic Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Antiasthmatic Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Antiasthmatic Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Antiasthmatic Drug Industry Trends
  2. 4.2 Antiasthmatic Drug Industry Drivers
  3. 4.3 Antiasthmatic Drug Industry Opportunities and Challenges
  4. 4.4 Antiasthmatic Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Antiasthmatic Drug Revenue (2021-2026)
  2. 5.2 Global Antiasthmatic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Antiasthmatic Drug Key Company Headquarters & Area Served
  4. 5.4 Global Antiasthmatic Drug Company, Product Type & Application
  5. 5.5 Global Antiasthmatic Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Antiasthmatic Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Antiasthmatic Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Antiasthmatic Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Ruiyang Pharmaceutical Co., Ltd
  2. 6.1.1 Ruiyang Pharmaceutical Co., Ltd Company Information
  3. 6.1.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
  4. 6.1.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  6. 6.1.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Antiasthmatic Drug Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Antiasthmatic Drug Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Lunan Pharmaceutical Group Co., Ltd
  20. 6.4.1 Lunan Pharmaceutical Group Co., Ltd Company Information
  21. 6.4.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
  22. 6.4.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio
  24. 6.4.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments
  25. 6.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd
  26. 6.5.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information
  27. 6.5.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
  28. 6.5.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  30. 6.5.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Antiasthmatic Drug Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Fuhe Group
  38. 6.7.1 Fuhe Group Company Information
  39. 6.7.2 Fuhe Group Business Overview
  40. 6.7.3 Fuhe Group Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Fuhe Group Antiasthmatic Drug Product Portfolio
  42. 6.7.5 Fuhe Group Recent Developments
  43. 6.8 Chengdu Huayu Pharmaceutical Co., Ltd
  44. 6.8.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Information
  45. 6.8.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
  46. 6.8.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  48. 6.8.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Antiasthmatic Drug Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Teva Pharmaceutical Industries Ltd
  56. 6.10.1 Teva Pharmaceutical Industries Ltd Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Ltd Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
  61. 6.11 Mundipharma Pharmaceuticals Ltd.
  62. 6.11.1 Mundipharma Pharmaceuticals Ltd. Company Information
  63. 6.11.2 Mundipharma Pharmaceuticals Ltd. Business Overview
  64. 6.11.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio
  66. 6.11.5 Mundipharma Pharmaceuticals Ltd. Recent Developments
  67. 6.12 MSD
  68. 6.12.1 MSD Company Information
  69. 6.12.2 MSD Business Overview
  70. 6.12.3 MSD Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 MSD Antiasthmatic Drug Product Portfolio
  72. 6.12.5 MSD Recent Developments
  73. 6.13 Kyorin Pharmaceutical Co.,Ltd.
  74. 6.13.1 Kyorin Pharmaceutical Co.,Ltd. Company Information
  75. 6.13.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
  76. 6.13.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio
  78. 6.13.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments
  79. 6.14 Kissei Pharmaceutical Co.Ltd.
  80. 6.14.1 Kissei Pharmaceutical Co.Ltd. Company Information
  81. 6.14.2 Kissei Pharmaceutical Co.Ltd. Business Overview
  82. 6.14.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
  84. 6.14.5 Kissei Pharmaceutical Co.Ltd. Recent Developments
  85. 6.15 Daiichi Sankyo Company Limited
  86. 6.15.1 Daiichi Sankyo Company Limited Company Information
  87. 6.15.2 Daiichi Sankyo Company Limited Business Overview
  88. 6.15.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio
  90. 6.15.5 Daiichi Sankyo Company Limited Recent Developments
  91. 6.16 Covis Pharmaceutical Inc
  92. 6.16.1 Covis Pharmaceutical Inc Company Information
  93. 6.16.2 Covis Pharmaceutical Inc Business Overview
  94. 6.16.3 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio
  96. 6.16.5 Covis Pharmaceutical Inc Recent Developments
  97. 6.17 Chiesi GmbH
  98. 6.17.1 Chiesi GmbH Company Information
  99. 6.17.2 Chiesi GmbH Business Overview
  100. 6.17.3 Chiesi GmbH Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Chiesi GmbH Antiasthmatic Drug Product Portfolio
  102. 6.17.5 Chiesi GmbH Recent Developments
  103. 6.18 Boehringer Ingelheim Pharma GmbH&Co.KG
  104. 6.18.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Information
  105. 6.18.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
  106. 6.18.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
  109. 6.19 Akorn Pharmaceutical Co.Ltd.
  110. 6.19.1 Akorn Pharmaceutical Co.Ltd. Company Information
  111. 6.19.2 Akorn Pharmaceutical Co.Ltd. Business Overview
  112. 6.19.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
  114. 6.19.5 Akorn Pharmaceutical Co.Ltd. Recent Developments
  115. 6.20 ABC Farmaceutici Spa
  116. 6.20.1 ABC Farmaceutici Spa Company Information
  117. 6.20.2 ABC Farmaceutici Spa Business Overview
  118. 6.20.3 ABC Farmaceutici Spa Antiasthmatic Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio
  120. 6.20.5 ABC Farmaceutici Spa Recent Developments
7 North America
  1. 7.1 North America Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Antiasthmatic Drug Market Size by Country (2021-2026)
  3. 7.3 North America Antiasthmatic Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Antiasthmatic Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Antiasthmatic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Antiasthmatic Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Antiasthmatic Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Antiasthmatic Drug Market Size by Country (2021-2026)
  3. 10.3 South America Antiasthmatic Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Antiasthmatic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Antiasthmatic Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst